At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
AMEPAROMO CAPSULES 250 MG DRUG USE INVESTIGATION
In Brief
An observational study for Intestinal Amebiasis. Completed, enrolled 120 participants.
Detailed Summary
This Study is intended to evaluate the safety and effectiveness of Ameparomo Capsules 250 mg under actual medical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIntestinal Amebiasis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
First PostedFeb 2016
Primary CompletionDec 2018
TodayJul 2026
First PostedFeb 11, 2016
Enrollment StartOct 19, 2015
Primary CompletionDec 21, 2018
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 10.4 years ago